The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•27 February 2026•

1 min read

US ITC Reaffirms GoPro Patent Claims Against Insta360, Issues Import Ban

FDA and Novo Nordisk logos above a laboratory scene with computer monitors, chemical structures, medicine bottles, and pills.

Key Facts

1The U.S. International Trade Commission (ITC) upheld a ruling that Insta360 imported and sold products infringing on GoPro's intellectual property.

The U.S. International Trade Commission (ITC) has upheld a ruling finding that Insta360 imported and sold products that infringe on GoPro's intellectual property rights. This decision reaffirms GoPro's patent infringement claims and marks a significant legal victory for the company in safeguarding its proprietary technology. As a result of the ruling, an exclusion order will prevent the importation of infringing Insta360 products into the United States market. Market analysts view this outcome as a positive catalyst for GoPro, as it effectively removes a major competitor's infringing products from its primary market. This legal protection is expected to bolster GoPro's market share and provide a competitive advantage for its action camera lineup. The enforcement of these patent rights underscores GoPro's commitment to protecting its innovations against global competitors and securing its long-term revenue streams.